Companies / Ligand Pharmaceuticals Inc / Activity

Activity — Ligand Pharmaceuticals Inc

110 moves.

Top impact Insider · CEO moves Insider · biggest buys Insider · biggest sells Institution · biggest moves Institution · new positions

Date	Actor	Action	Security	Value	Shares Δ	Position after	Impact
Mar 4, 2026	Reardon Andrew Executive	Sell	Common Stock	$41.4K	-207 -0.50%	41,462 0.21% of shares	low
Mar 4, 2026	Reardon Andrew Executive	Sell	Common Stock	$40.8K	-200 -0.49%	40,869 0.21% of shares	low
Mar 2, 2026	Kozarich John W Director	Sell	Common Stock	$40.7K	-204 -0.47%	42,936 0.22% of shares	low
Jan 2, 2026	Kozarich John W Director	Sell	Common Stock	$39.4K	-207 -0.47%	43,700 0.22% of shares	low
May 1, 2026	Kozarich John W Director	Sell	Common Stock	$38.3K	-165 -0.39%	42,007 0.21% of shares	low
Mar 4, 2026	Espinoza Octavio Executive	Exercise	Common Stock	$37.6K	+466 +1.35%	35,085 0.18% of shares	low
Apr 1, 2026	Kozarich John W Director	Sell	Common Stock	$32.5K	-159 -0.37%	42,253 0.21% of shares	low
May 12, 2026	Kozarich John W Director	Exercise	Common Stock	$31.9K	+459 +1.10%	42,245 0.21% of shares	low
Apr 1, 2026	Kozarich John W Director	Sell	Common Stock	$29.2K	-146 -0.34%	42,574 0.21% of shares	low
May 1, 2026	Kozarich John W Director	Sell	Common Stock	$27.2K	-116 -0.28%	41,786 0.21% of shares	low
May 1, 2026	Kozarich John W Director	Sell	Common Stock	$24.4K	-105 -0.25%	41,902 0.21% of shares	low
Mar 4, 2026	Reardon Andrew Executive	Sell	Common Stock	$19.9K	-100 -0.24%	41,669 0.21% of shares	low
Mar 4, 2026	Reardon Andrew Executive	Sell	Common Stock	$19.8K	-100 -0.24%	41,769 0.21% of shares	low
Jan 2, 2026	Kozarich John W Director	Sell	Common Stock	$19.3K	-102 -0.23%	43,907 0.22% of shares	low
Mar 4, 2026	Reardon Andrew Executive	Sell	Common Stock	$18.7K	-93 -0.22%	41,369 0.21% of shares	low
May 1, 2026	Kozarich John W Director	Sell	Common Stock	$18.2K	-80 -0.19%	42,173 0.21% of shares	low
Jan 2, 2026	Kozarich John W Director	Sell	Common Stock	$17.1K	-91 -0.21%	44,009 0.22% of shares	low
Mar 2, 2026	Kozarich John W Director	Sell	Common Stock	$16.7K	-83 -0.19%	42,812 0.21% of shares	low
Apr 1, 2026	Kozarich John W Director	Sell	Common Stock	$16.0K	-79 -0.19%	42,455 0.21% of shares	low
Mar 4, 2026	Espinoza Octavio Executive	Sell	Common Stock	$10.6K	-53 -0.15%	34,333 0.17% of shares	low
Mar 2, 2026	Kozarich John W Director	Sell	Common Stock	$10.1K	-50 -0.12%	42,762 0.21% of shares	low
Mar 2, 2026	Kozarich John W Director	Sell	Common Stock	$9.3K	-47 -0.11%	43,140 0.22% of shares	low
Jan 2, 2026	Kozarich John W Director	Sell	Common Stock	$8.9K	-46 -0.11%	43,654 0.22% of shares	low
Apr 1, 2026	Kozarich John W Director	Sell	Common Stock	$8.7K	-43 -0.10%	42,412 0.21% of shares	low
Mar 2, 2026	Kozarich John W Director	Sell	Common Stock	$8.5K	-42 -0.10%	42,720 0.21% of shares	low
Mar 2, 2026	Kozarich John W Director	Sell	Common Stock	$8.2K	-41 -0.10%	42,895 0.22% of shares	low
Apr 1, 2026	Kozarich John W Director	Sell	Common Stock	$8.0K	-40 -0.09%	42,534 0.21% of shares	low
Feb 2, 2026	Kozarich John W Director	Sell	Common Stock	$7.4K	-39 -0.09%	43,615 0.22% of shares	low
Feb 2, 2026	Kozarich John W Director	Sell	Common Stock	$4.5K	-23 -0.05%	43,187 0.22% of shares	low
Feb 2, 2026	Kozarich John W Director	Sell	Common Stock	$4.5K	-23 -0.05%	43,591 0.22% of shares	low
Jan 2, 2026	Kozarich John W Director	Sell	Common Stock	$3.9K	-21 -0.05%	44,100 0.22% of shares	low
Dec 31, 2025	Espinoza Octavio Executive	Other	Common Stock	$765	+8 +0.03%	28,575 0.14% of shares	low
May 1, 2026	Kozarich John W Director	Sell	Common Stock	$230	-1 -0.00%	42,172 0.21% of shares	low
Feb 2, 2026	Kozarich John W Director	Sell	Common Stock	$192	-1 -0.00%	43,614 0.22% of shares	low
Jun 5, 2026	Aryeh Jason Director	Grant	Common Stock	$0	+836 +0.78%	107,580 0.54% of shares	low
Jun 5, 2026	Kozarich John W Director	Grant	Common Stock	$0	+836 +2.00%	42,622 0.21% of shares	low
Jun 5, 2026	Lamattina John L Director	Grant	Common Stock	$0	+836 +2.72%	31,560 0.16% of shares	low
Feb 14, 2026	Reardon Andrew Executive	Grant	Common Stock	$0	+9K +25.52%	43,338 0.22% of shares	low
Feb 14, 2026	Reardon Andrew Executive	Grant	Common Stock	$0	+7K +22.49%	37,739 0.19% of shares	low
Feb 14, 2026	Espinoza Octavio Executive	Grant	Common Stock	$0	+9K +27.36%	41,014 0.21% of shares	low
Feb 14, 2026	Espinoza Octavio Executive	Grant	Common Stock	$0	+7K +25.86%	35,965 0.18% of shares	low
Mar 2, 2026	Espinoza Octavio Executive	Grant	Common Stock	$0	+5K +14.94%	37,945 0.19% of shares	low
Mar 2, 2026	Davis Todd C CEO	Grant	Common Stock	$0	+10K +5.56%	199,381 1.00% of shares	low
Mar 2, 2026	Reardon Andrew Executive	Grant	Common Stock	$0	+5K +12.24%	41,382 0.21% of shares	low
Feb 14, 2026	Davis Todd C CEO	Grant	Common Stock	$0	+40K +22.79%	213,585 1.07% of shares	low
Feb 14, 2026	Davis Todd C CEO	Grant	Common Stock	$0	+21K +12.88%	182,119 0.91% of shares	low
Jun 5, 2026	Aryeh Jason Director	Grant	Non-Qualified Stock Option (right to buy)	—	+3K	2,938 0.01% of shares	low
Jun 5, 2026	Kozarich John W Director	Grant	Non-Qualified Stock Option (right to buy)	—	+3K	2,938 0.01% of shares	low
May 13, 2026	Kozarich John W Director	Exercise	Non-Qualified Stock Option (right to buy)	—	-2K -100.00%	0 0.00% of shares	low
May 12, 2026	Kozarich John W Director	Exercise	Non-Qualified Stock Option (right to buy)	—	-459 -22.57%	1,575 <0.01% of shares	low